The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 7
  • 1
    Conroy, Lucille, Dr
    Director born in January 1990
    Individual (1 offspring)
    Officer
    2024-06-28 ~ now
    OF - Director → CIF 0
  • 2
    Tobin, Jonathan Leslie
    Venture Capitalist born in December 1982
    Individual (6 offsprings)
    Officer
    2023-04-19 ~ now
    OF - Director → CIF 0
  • 3
    Carr, Robin Arthur Ellis, Dr
    Ceo born in October 1960
    Individual (1 offspring)
    Officer
    2022-10-11 ~ now
    OF - Director → CIF 0
  • 4
    Bhaman, Maina
    Venture Capitalist born in February 1972
    Individual (5 offsprings)
    Officer
    2019-10-29 ~ now
    OF - Director → CIF 0
  • 5
    Bauer, Michael Karl
    Partner born in October 1963
    Individual (1 offspring)
    Officer
    2024-06-28 ~ now
    OF - Director → CIF 0
  • 6
    Martin, Christopher John, Dr
    Engineer born in July 1958
    Individual (8 offsprings)
    Officer
    2023-11-10 ~ now
    OF - Director → CIF 0
  • 7
    ENFRANCHISE SECRETARIAL SERVICES LIMITED - 1992-02-04
    125, Wood Street, London, United Kingdom
    Active Corporate (6 parents, 215 offsprings)
    Equity (Company account)
    2 GBP2024-03-31
    Officer
    2025-02-11 ~ now
    OF - Secretary → CIF 0
Ceased 6
  • 1
    Tate, Edward William, Professor
    Company Director born in October 1975
    Individual
    Officer
    2019-07-03 ~ 2024-06-28
    OF - Director → CIF 0
    Professor Edward William Tate
    Born in October 1975
    Individual
    Person with significant control
    2019-07-03 ~ 2019-10-30
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 2
    Hawthorne, Grant
    Individual (14 offsprings)
    Officer
    2019-12-20 ~ 2024-11-30
    OF - Secretary → CIF 0
  • 3
    Brake, Rachael
    Scientist born in July 1971
    Individual
    Officer
    2021-02-23 ~ 2024-06-19
    OF - Director → CIF 0
  • 4
    Paoletti, Paolo, Dr
    Md, Consultant, Advisor, Board Member born in October 1950
    Individual
    Officer
    2024-09-20 ~ 2025-01-27
    OF - Director → CIF 0
  • 5
    Thompson, Henry Stephen Grammer, Dr
    Director born in October 1961
    Individual
    Officer
    2019-10-29 ~ 2023-04-19
    OF - Director → CIF 0
  • 6
    Solari, Roberto Celeste Ercole, Dr
    Company Director born in November 1956
    Individual (2 offsprings)
    Officer
    2019-07-03 ~ 2023-11-10
    OF - Director → CIF 0
parent relation
Company in focus

MYRICX PHARMA LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
82022-08-01 ~ 2023-07-31
62021-08-01 ~ 2022-07-31
Property, Plant & Equipment
47,482 GBP2023-07-31
64,852 GBP2022-07-31
Fixed Assets
47,482 GBP2023-07-31
64,852 GBP2022-07-31
Debtors
Current
607,579 GBP2023-07-31
667,735 GBP2022-07-31
Cash at bank and in hand
985,106 GBP2023-07-31
1,526,888 GBP2022-07-31
Current Assets
1,592,685 GBP2023-07-31
2,194,623 GBP2022-07-31
Creditors
Current, Amounts falling due within one year
-5,313,831 GBP2023-07-31
-276,188 GBP2022-07-31
Net Current Assets/Liabilities
-3,721,146 GBP2023-07-31
1,918,435 GBP2022-07-31
Total Assets Less Current Liabilities
-3,673,664 GBP2023-07-31
1,983,287 GBP2022-07-31
Creditors
Non-current, Amounts falling due after one year
-3,162,247 GBP2022-07-31
Net Assets/Liabilities
-3,684,834 GBP2023-07-31
-1,195,085 GBP2022-07-31
Equity
Called up share capital
76 GBP2023-07-31
76 GBP2022-07-31
Share premium
4,999,950 GBP2023-07-31
4,999,950 GBP2022-07-31
Retained earnings (accumulated losses)
-8,684,860 GBP2023-07-31
-6,195,111 GBP2022-07-31
Equity
-3,684,834 GBP2023-07-31
-1,195,085 GBP2022-07-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
202022-08-01 ~ 2023-07-31
Office equipment
202022-08-01 ~ 2023-07-31
Computers
202022-08-01 ~ 2023-07-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
90,511 GBP2023-07-31
90,511 GBP2022-07-31
Office equipment
694 GBP2023-07-31
694 GBP2022-07-31
Computers
7,919 GBP2023-07-31
5,045 GBP2022-07-31
Property, Plant & Equipment - Gross Cost
99,124 GBP2023-07-31
96,250 GBP2022-07-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
29,131 GBP2022-07-31
Office equipment
335 GBP2022-07-31
Computers
1,932 GBP2022-07-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
31,398 GBP2022-07-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
18,102 GBP2022-08-01 ~ 2023-07-31
Office equipment, Owned/Freehold
139 GBP2022-08-01 ~ 2023-07-31
Computers, Owned/Freehold
2,003 GBP2022-08-01 ~ 2023-07-31
Owned/Freehold
20,244 GBP2022-08-01 ~ 2023-07-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
47,233 GBP2023-07-31
Office equipment
474 GBP2023-07-31
Computers
3,935 GBP2023-07-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
51,642 GBP2023-07-31
Property, Plant & Equipment
Plant and equipment
43,278 GBP2023-07-31
61,380 GBP2022-07-31
Office equipment
220 GBP2023-07-31
359 GBP2022-07-31
Computers
3,984 GBP2023-07-31
3,113 GBP2022-07-31
Other Debtors
Current
575,434 GBP2023-07-31
652,029 GBP2022-07-31
Prepayments/Accrued Income
Current
32,145 GBP2023-07-31
15,706 GBP2022-07-31
Other Remaining Borrowings
Current
4,924,475 GBP2023-07-31
Trade Creditors/Trade Payables
Current
370,912 GBP2023-07-31
155,199 GBP2022-07-31
Taxation/Social Security Payable
Current
14,580 GBP2023-07-31
24,865 GBP2022-07-31
Other Creditors
Current
864 GBP2023-07-31
354 GBP2022-07-31
Accrued Liabilities/Deferred Income
Current
3,000 GBP2023-07-31
95,770 GBP2022-07-31
Creditors
Current
5,313,831 GBP2023-07-31
276,188 GBP2022-07-31
Other Remaining Borrowings
Non-current
3,162,247 GBP2022-07-31
Net Deferred Tax Liability/Asset
-11,170 GBP2023-07-31
-16,125 GBP2022-07-31
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
4,955 GBP2022-08-01 ~ 2023-07-31
Deferred Tax Liabilities
Accelerated tax depreciation
-11,170 GBP2023-07-31
-16,125 GBP2022-07-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
5,000,000 shares2023-07-31
5,000,000 shares2022-07-31
Par Value of Share
Class 1 ordinary share
0.000012022-08-01 ~ 2023-07-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
800,000 shares2023-07-31
800,000 shares2022-07-31
Par Value of Share
Class 2 ordinary share
0.000012022-08-01 ~ 2023-07-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
1,800,000 shares2023-07-31
1,800,000 shares2022-07-31
Par Value of Share
Class 3 ordinary share
0.000012022-08-01 ~ 2023-07-31

  • MYRICX PHARMA LIMITED
    Info
    Registered number 12082645
    125 Wood Street, London EC2V 7AW
    Private Limited Company incorporated on 2019-07-03 (6 years). The company status is Active.
    The last date of confirmation statement was made at 2024-07-02
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.